2024 annual financial data
CNS Pharmaceuticals 2024 Operating margin
CNS Pharmaceuticals 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -14,901,943 USD and net income was -14,857,801 USD.
Operating cash flow was -17,113,299 USD.
Get free CNS Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -14,901,943 USD
- Net income
- -14,857,801 USD
- Operating cash flow
- -17,113,299 USD